Breaking News on Top Traded Stocks and Penny Stocks: Facebook, Best Buy, Intel, Oracle, JPMorgan, and J.C. Penney



Insiderslab.com has issued insider trading reports and equity research for the following companies: Facebook (NASDAQ:FB), Best Buy (NYSE:BBY), Intel (NASDAQ:INTC), Oracle (NASDAQ:ORCL), JPMorgan (NYSE:JPM), and J.C. Penney (NYSE:JCP).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Facebook Inc. (NASDAQ:FB): Insiderslab.com found Facebook Inc. (NASDAQ:FB) Vice President - Marketing and Business Partnerships, David B. Fischer, totally sold 24,000 shares on December 11 and December 12, for a worth of US$672,840. Disclose date: December 13. Between September 15 and December 14, Facebook insiders have totally sold US$207.03 million worth of stock, according to insider trading report. Do you think now is a good time to buy or sell the stock? Do you want to know when Facebook insiders will purchase their shares? See insider trade report for FB here.
 
Read Full Report: http://www.insiderslab.com/PR3/121712A/FB/Facebook.pdf
 
Best Buy Co., Inc. (NYSE:BBY): Best Buy Co., Inc. (NYSE:BBY) agreed to extend the deadline to February 28, 2013 for founder Richard Schulze to make a bid for the company. Following the announcement, shares of Best Buy plunged US$2.07 (or -14.66%) to US$12.05 on hefty volume of 42.31 million shares, above its average volume of 10.97 million shares. Investors may want to find out how Best Buy insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for BBY here.
 
Read Full Report: http://www.insiderslab.com/PR3/121712A/BBY/BestBuy.pdf
 
Intel Corporation (NASDAQ:INTC): In the last three months, Intel Corporation (NASDAQ:INTC) insiders have totally made Market Option Sale for about US$581,130, which ranged in price from US$21.50 to US$21.62 each. In the past 52 weeks, Intel share prices have been bracketed by a low of US$19.23 and a high of US$29.27, and are now at US$20.53 (7% above that low price). Check this insider trade report for INTC here.
 
Read Full Report: http://www.insiderslab.com/PR3/121712A/INTC/Intel.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Oracle Corporation (NASDAQ:ORCL):
Read Full Report: http://www.insiderslab.com/PR3/121712A/ORCL/Oracle.pdf
 
JPMorgan Chase & Co. (NYSE:JPM):
Read Full Report: http://www.insiderslab.com/PR3/121712A/JPM/JPMorgan.pdf
 
J.C. Penney Company, Inc. (NYSE:JCP):
Read Full Report: http://www.insiderslab.com/PR3/121712A/JCP/JCPenney.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
 
CONTACT: Insiders.hk, Insiderslab.com, info@insiderslab.com, Support@insiders.hk
SOURCE Insiderslab.com; Insiders.hk
Editor: Janet Nan Jiang
 
 
Source:
insiderslab.com
www.insiderslab.com

Reported on Dec 17, 2012

 
More Insider News ...

Today's Notable Trades


GILEAD SCIENCES INC (GILD)
Director: Cogan John Francis

Sold 13,902 Common Stock (Non-Derivative security at $104.030) on Oct 21, 2014. Direct holding 43,503 shares/units after transaction. Holdings decreased -24.22%.
Filing date: Oct 23, 2014. Record updated at 15:02:11.
 
WD 40 CO (WDFC)
Director: COLLATO RICHARD A

Sold 2,127 Common Stock (Non-Derivative security at $75.000) on Oct 22, 2014. Direct holding 12,787 shares/units after transaction. Holdings decreased -14.26%.
Filing date: Oct 23, 2014. Record updated at 15:02:10.
 
CARLISLE COMPANIES INC (CSL)
Senior Officer (V.P., Chief Financial Officer): FORD STEVEN J

Sold 20,000 Common Stock (Non-Derivative security at $85.196) on Oct 22, 2014. Direct holding 83,574 shares/units after transaction. Holdings decreased -19.31%.
Filing date: Oct 23, 2014. Record updated at 15:02:09.
 
RE/MAX Holdings, Inc. (RMAX)
Senior Officer (EVP and CLO): LEWIS GEOFFREY D

Sold 2,414 Class A Common Stock (Non-Derivative security at $32.000) on Oct 22, 2014. Direct holding 16,213 shares/units after transaction. Holdings decreased -12.96%.
Filing date: Oct 23, 2014. Record updated at 15:02:04.
 
VERIZON COMMUNICATIONS INC (VZ)
Senior Officer (EVP - Pub Policy & Gen Counsel): MILCH RANDAL S

Sold 2,790 Common Stock (Non-Derivative security at $48.610) on Oct 22, 2014. Direct holding 3,494 shares/units after transaction. Holdings decreased -44.40%.
Filing date: Oct 23, 2014. Record updated at 15:01:53.
 
COSTCO WHOLESALE CORP /NEW (COST)
Other: PETTERSON DAVID S

Sold 15,400 Common Stock (Non-Derivative security at $131.137) on Oct 23, 2014. Direct holding 23,538 shares/units after transaction. Holdings decreased -39.55%.
Filing date: Oct 23, 2014. Record updated at 15:01:26.
 
BOSTON BEER CO INC (SAM)
First-Class Insider (President and C.E.O.): ROPER MARTIN F

Sold 2,200 Class A Common (Non-Derivative security at $220.170) on Oct 22, 2014. Direct holding 3,830 shares/units after transaction. Holdings decreased -36.48%.
Filing date: Oct 23, 2014. Record updated at 15:01:18.
 
MONARCH CASINO & RESORT INC (MCRI)
First-Class Insider (President): FARAHI BOB

Acquired 33,334 Option/right to buy (Derivative security at conversion or exercise price: $12.320) on Oct 21, 2014. Direct holding 200,004 shares/units after transaction. Option/right to buy expires on Oct 21, 24. Holdings increased 20.00%.
Filing date: Oct 23, 2014. Record updated at 13:01:28.
 
HUNTINGTON BANCSHARES INC/MD (HBAN)
Senior Officer (Regional Banking Group Pres.): Dunlap James E

Acquired 47,253 Common Stock (Non-Derivative security at $6.020) on Oct 21, 2014. Direct holding 275,177 shares/units after transaction. Holdings increased 20.73%.
Filing date: Oct 23, 2014. Record updated at 13:01:24.
 
Atara Biotherapeutics, Inc. (ATRA)
10% shareholder: Domain Partners VIII, L.P.

Acquired 248,159 Common Stock (Non-Derivative security at $11.000) on Oct 21, 2014. Direct holding 2,141,542 shares/units after transaction. Holdings increased 13.11%.
Filing date: Oct 21, 2014. Record updated at 11:09:28.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.